Ankylosing spondylitis early diagnosis, early treatment

Chun Hsiung Chen, Hsien Tzung Liao, Toong Hua Liang, Chung Tei Chou

研究成果: 雜誌貢獻文章同行評審


Ankylosing spondylitis is a common chronic inflammatory rheumatic disease, characterized by axial joint inflammation, peripheral arthritis, and enthesopathy. It primarily affect young male, and has strong linkage with HLA-B27. Persistent inflammation could lead to the bony growth or syndesmophyte, ankylosing of the adjacent vertebral body, and loss of functional ability. Exercise and nonsteroidal anti-inflammatory drugs (NSAIDs) are the standard therapy for the patients with ankylosing spondylitis. Sulfasalazine is helpful in the patients with peripheral arthritis. Local steroids injections are also widely used in refractory enthesopathy and peripheral arthritis. The most important progress in the treatment of ankylosing spondylitis is the newly development of anti-tumor necrosis factor-α (TNF-α) drugs. Patient's can achieve rapid, significant and sustained improvement with these biologic agent.

頁(從 - 到)481-490
期刊Journal of Internal Medicine of Taiwan
出版狀態已發佈 - 12月 2008

ASJC Scopus subject areas

  • 內科學


深入研究「Ankylosing spondylitis early diagnosis, early treatment」主題。共同形成了獨特的指紋。